Updated Results of a Phase II Study: Neoadjuvant Inetetamab Combined with Pertuzumab, Paclitaxel and Carboplatin for Locally Advanced HER2-Positive Breast Cancer

被引：0
|
作者：
Chai, Yue
Liu, Jiaxuan
Jiang, Mingxia
He, Maiyue
Wang, Xin
Wang, Yipeng
Yang, Xue
Wang, Jing
Xu, Binghe
Li, Qiao
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-18-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-18-12
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Real-world study of trastuzumab and pertuzumab combined with chemotherapy in neoadjuvant treatment for patients with HER2-positive breast cancer
    Ma, Xiangmin
    Zhang, Xiangmei
    Zhou, Xinping
    Ren, Xiaofei
    Ma, Xindi
    Zhang, Weifang
    Yang, Ruiling
    Song, Tao
    Liu, Yunjiang
    MEDICINE, 2022, 101 (40) : E30892
  • [42] Neoadjuvant Chemotherapy with or without Anthracyclines Combined with Trastuzumab and Pertuzumab in HER2-Positive Breast Cancer: A Multicenter Retrospective Study in China
    Zhang, Y.
    Zhou, J.
    Yang, S.
    Li, G.
    Wang, X.
    Bai, L.
    Zhang, S.
    Cao, W.
    Ouyang, T.
    Jiang, Z.
    He, Y.
    Wang, T.
    Fan, Z.
    BREAST, 2025, 80
  • [43] A Phase Ib/II Trial of Trastuzumab-DM1 with Pertuzumab for Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer: Interim Efficacy and Safety Results
    Dieras, V.
    Harbeck, N.
    Albain, K.
    Burris, H.
    Awada, A.
    Crivellari, D.
    Andre, F.
    Choi, Y. J.
    Huang, J.
    Miller, K. D.
    CANCER RESEARCH, 2010, 70
  • [44] Effect of Weekly Carboplatin and Paclitaxel with Trastuzumab and Pertuzumab (wPCbTP) on Nodal Disease and Surgical Options in HER2-positive Breast Cancer
    Ciambella, Chelsey
    Dizon, Don
    Taneja, Charu
    Graves, Theresa
    Lopresti, Mary
    Sikov, William
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S421 - S422
  • [45] Phase II study of neoadjuvant NALIRIFOX followed by chemoradiation with paclitaxel and carboplatin in locally advanced gastroesophageal cancer
    Yon-Li Wo, Jennifer
    Strickland, Matthew
    Yeap, Beow Y.
    Guan, Zoe
    Keane, Florence
    Roberts, Hannah Johnson
    Morse, Christopher
    Lanuti, Michael
    Mullen, John Thomas
    Sachdeva, Uma
    Auchincloss, Hugh G.
    Mendel, Bailey
    Drapek, Lorraine C.
    Meurer, Jessica
    Blaszkowsky, Lawrence Scott
    Clark, jeffrey William
    Hong, Theodore S.
    Klempner, Samuel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 452 - 452
  • [46] Surgical aspect in NOAH Phase III trial (neoadjuvant trastuzumab in HER2-positive locally advanced breast cancer)
    Semiglazov, V.
    Eiermann, W.
    Manikhas, A.
    Bozok, A.
    Lluch, A.
    Tjulandine, S.
    Feyereislova, A.
    Valagussae, P.
    Baselga, J.
    Gianni, L.
    EJC SUPPLEMENTS, 2008, 6 (07): : 169 - 170
  • [47] A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
    Patel, Tejal A.
    Ensor, Joe E.
    Creamer, Sarah L.
    Boone, Toniva
    Rodriguez, Angel A.
    Niravath, Poly A.
    Darcourt, Jorge G.
    Meisel, Jane L.
    Li, Xiaoxian
    Zhao, Jing
    Kuhn, John G.
    Rosato, Roberto R.
    Qian, Wei
    Belcheva, Anna
    Schwartz, Mary R.
    Kaklamani, Virginia G.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [48] Phase II trial of paclitaxel combined with trastuzumab and pertuzumab as preoperative therapy for HER2 positive inflammatory breast cancer
    Overmoyer, B. A.
    Regan, M.
    Brugge, J.
    Perou, C. M.
    Nakhlis, F.
    Jennifer, B.
    Heather, J.
    Eren, Y. D.
    Judith, H-B
    Winer, E.
    CANCER RESEARCH, 2013, 73
  • [49] A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
    Tejal A. Patel
    Joe E. Ensor
    Sarah L. Creamer
    Toniva Boone
    Angel A. Rodriguez
    Poly A. Niravath
    Jorge G. Darcourt
    Jane L. Meisel
    Xiaoxian Li
    Jing Zhao
    John G. Kuhn
    Roberto R. Rosato
    Wei Qian
    Anna Belcheva
    Mary R. Schwartz
    Virginia G. Kaklamani
    Jenny C. Chang
    Breast Cancer Research, 21
  • [50] Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience
    Kim, Ji-Yeon
    Nam, Seok Jin
    Lee, Jeong Eon
    Yu, Jonghan
    Chae, Byung Joo
    Lee, Se Kyung
    Ryu, Jai Min
    Ahn, Jin Seok
    Im, Young-Hyuck
    Kim, Seok Won
    Park, Yeon Hee
    CANCER RESEARCH AND TREATMENT, 2022, 54 (04): : 1091 - 1098
12345